“When you are finished changing, you are finished.”
Companies that don’t change can have the worst possible thing happen to them: they will stay in one place. It’s not unusual to fear change, but those businesses that don’t embrace it will see their competitors surpass them while their customers leave them in a steady stream.
This isn’t to say that a headlong rush into change for change’s sake is a sound strategy. Too often, companies assume they know what their customers’ needs are and begin costly and time-consuming product development without the necessary due diligence. Often what results are failed launches, lost resources, and time with no return on investment, and worst of all, unhappy customers with a solution they might never have needed.
“We employ a strategic and systematic approach to engaging our client-base for their ideas as to how to improve our offerings as well as to create new products to meet their needs.”
Hayes is driven by client-focused innovation. It is the input of our payer and provider clients that define our forward progress, specifically the development of new products. We don’t work on assumptions. We employ a strategic and systematic approach to engaging our client-base for their ideas as to how to improve our offerings as well as to create new products to meet their needs.
We engage our clients in user experience workshops and innovation roundtables, at events such as our Client Symposium (you can learn about and register for our 2017 Symposium here). We also arrange on-site visits, where we can observe the intricacies of how our services integrate with client workflows in order to best understand how to streamline the process.
“There must be the agility within the process to recognize that the rapid change that occurs in the healthcare field can quickly make a new product obsolete.”
Our innovation strategy relies on use of the Stage-Gate model, a well-established methodology for new product innovation and development. At a high level, the stages for a new product are:
- Idea Generation (from the above mentioned scenarios; sometimes referred to as stage 0)
- Stage 1: Scoping (preliminary investigation and scoping)
- Stage 2: Build the Business Case (detailed investigation; propose plan for development)
- Stage 3: Development (actual design and development)
- Stage 4: Testing and Validation (tests or trials in the marketplace)
- Stage 5: Launch (commercialization, production, and marketing)
The methodology is flexible in that at no point are we “locked in.” Prior to the beginning of the next stage, a “Go/No Go” decision is made. Because each stage can take a considerable amount of time, there must be the agility within the process to recognize that the rapid change that occurs in the healthcare field can quickly make a new product obsolete.
Our innovation does not occur without you. We don’t want you to wait for an annual gathering for an on-site visit to communicate your ideas with us. Contact us directly with ideas or suggestions for a new product, service, or improvements to existing products or services.
In the meantime, take a look at an example of your ideas at work. The Genetic Test Evaluation (GTE) Indication report was an innovation that came from your needs and suggestions. View a sample of one of our most recent indication reports, “Genetic Testing for Fragile X Syndrome” by clicking below.
Welcome to the Innovation Team!